28262 Federal Register / Vol. 75, No. 97 / Thursday, May 20, 2010 / Notices 

MATTERS TO BE DISCUSSED: The meeting 

will include the initial review, 

discussion, and evaluation of 

applications received in response to 

‘‘Improved Diagnostics Lyme 

Borreliosis,’’ FOA CK10–005. 

FOR MORE INFORMATION CONTACT: 

Christine J. Morrison, PhD, Scientific 

Review Officer, CDC, 1600 Clifton Road, 

NE., Mailstop D72, Atlanta, GA 30333, 

Telephone: (404) 639–3098. 

The Director, Management Analysis 

and Services Office, has been delegated 

the authority to sign Federal Register 

notices pertaining to announcements of 

meetings and other committee 

management activities, for both CDC 

and the Agency for Toxic Substances 

and Disease Registry. 

Dated: May 6, 2010. 

Elaine L. Baker, 

Director, Management Analysis and Services 

Office, Centers for Disease Control and 

Prevention. 

[FR Doc. 2010–12167 Filed 5–19–10; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Office of the Director, National 

Institutes of Health; Notice of Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable materials, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

The meeting will be open to the 

public as indicated below, with 

attendance limited to space available. 

Individuals who plan to attend and 

need special assistance, such as sign 

language interpretation or other 

reasonable accommodations, should 

notify the Contact Person listed below 

in advance of the meeting. 

Name of Committee: Advisory Committee 

to the Director, NIH. 

Date: June 10, 2010. 

Closed: 8:30 a.m. to 9:30 p.m. 

Agenda: The ACD review of the Pioneer 

and Innovator Awards. 

Place: National Institutes of Health, 

Building 31, Conference Room 6, 9000 

Rockville Pike, Bethesda, MD 20892. 

Open: 9:30 a.m. to 5 p.m. 

Agenda: Among the topics proposed for 

discussion are: (1) NIH Director’s Report; (2) 

Work Group for Human Embryonic Stem Cell 

Review; (3) Work Group on Outside Awards 

for NIH Employees. 

Place: National Institutes of Health, 

Building 31, Conference Room 6, 9000 

Rockville Pike, Bethesda, MD 20852. 

Contact Person: Penny W. Burgoon, PhD, 

Senior Assistant to the Deputy Director, 

Office of the Director, National Institutes of 

Health, 1 Center Drive, Building 1, Room 

114, Bethesda, MD 20892. 

Any interested person may file written 

comments with the committee by forwarding 

the statement to the Contact Person listed on 

this notice. The statement should include the 

name, address, telephone number and when 

applicable, the business or professional 

affiliation of the interested person. 

In the interest of security, NIH has 

instituted stringent procedures for entrance 

onto the NIH campus. All visitor vehicles, 

including taxicabs, hotel, and airport shuttles 

will be inspected before being allowed on 

campus. Visitors will be asked to show one 

form of identification (for example, a 

government-issued photo ID, driver’s license, 

or passport) and to state the purpose of their 

visit. 

Information is also available on the Office 

of the Director’s home page: http:// 

www.nih.gov/about/director/acd.htm, where 

an agenda and any additional information for 

the meeting will be posted when available. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.14, Intramural Research 

Training Award; 93.22, Clinical Research 

Loan Repayment Program for Individuals 

from Disadvantaged Backgrounds; 93.232, 

Loan Repayment Program for Research 

Generally; 93.39, Academic Research 

Enhancement Award; 93.936, NIH Acquired 

Immunodeficiency Syndrome Research Loan 

Repayment Program; 93.187, Undergraduate 

Scholarship Program for Individuals from 

Disadvantaged Backgrounds, National 

Institutes of Health, HHS) 

Dated: May 14, 2010. 

Jennifer Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2010–12160 Filed 5–19–10; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Center for Research 

Resources; Notice of Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Center for 

Research Resources Special Emphasis Panel. 

Date: June 1, 2010. 

Time: 11 a.m. to 1 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, NCRR, 

OR, One Democracy Plaza, 6701 Democracy 

Blvd., Rm. 1064, Bethesda, MD 20892. 

Contact Person: Guo Zhang, MD, PhD, 

Scientific Review Officer, Office of Review, 

National Center for Research Resources, 

National Institutes of Health, 6701 

Democracy Blvd., 1 Democracy Plaza, Rm. 

1064, Bethesda, MD 20892–4874, 301–435– 

0812, zhanggu@mail.nih.gov. 

This notice is being published less than 15 

days prior to the meeting due to the urgent 

need to meet timing limitations imposed by 

the intramural research review cycle. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.306, Comparative Medicine; 

93.333, Clinical Research; 93.371, Biomedical 

Technology; 93.389, Research Infrastructure; 

93.306, 93.333, 93.702, ARRA Related 

Construction Awards, National Institutes of 

Health, HHS) 

Dated: May 14, 2010. 

Jennifer Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2010–12159 Filed 5–19–10; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Center on Minority Health and 

Health Disparities; Notice of Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of a meeting of the 

National Advisory Council on Minority 

Health and Health Disparities. 

The meeting will be open to the 

public as indicated below, with 

attendance limited to space available. 

Individuals who plan to attend and 

need special assistance, such as sign 

language interpretation or other 

reasonable accommodations, should 

notify the Contact Person listed below 

in advance of the meeting. 

The meeting will be closed to the 

public in accordance with the 


wwoods2 on DSK1DXX6B1PROD with NOTICES_PART 1
Federal Register / Vol. 75, No. 97 / Thursday, May 20, 2010 / Notices 28263 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications 

and/or contract proposals and the 

discussions could disclose confidential 

trade secrets or commercial property 

such as patentable material, and 

personal information concerning 

individuals associated with the grant 

applications and/or contract proposals, 

the disclosure of which would 

constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Advisory 

Council on Minority Health and Health 

Disparities. 

Date: June 8, 2010. 

Closed: 8 a.m. to 9 a.m. 

Agenda: To review and evaluate grant 

applications and/or proposals. 

Place: Bethesda Marriott Suites, 6711 

Democracy Boulevard, Bethesda, MD 20817. 

Open: 9 a.m. to 5 p.m. 

Agenda: The agenda will include opening 

remarks, administrative matters, Director’s 

Report, NIH Health Disparities update, and 

other business of the Council. 

Place: Bethesda Marriott Suites, 6711 

Democracy Boulevard, Bethesda, MD 20817. 

Contact Person: Donna Brooks, Asst. 

Director for Administration, National Center 

on Minority Health and Heath Disparities, 

National Institutes of Health, 6707 

Democracy Blvd., Suite 800, Bethesda, MD 

20892, (301) 435–2135. 

Any member of the public interested 

in presenting oral comments to the 

committee may notify the Contact 

Person listed on this notice at least 10 

days in advance of the meeting. 

Interested individuals and 

representatives of organizations may 

submit a letter of intent, a brief 

description of the organization 

represented, and a short description of 

the oral presentation. Only one 

representative of an organization may be 

allowed to present oral comments and if 

accepted by the committee, 

presentations may be limited to five 

minutes. Both printed and electronic 

copies are requested for the record. In 

addition, any interested person may file 

written comments with the committee 

by forwarding their statement to the 

Contact Person listed on this notice. The 

statement should include the name, 

address, telephone number and when 

applicable, the business or professional 

affiliation of the interested person. 

Dated: May 14, 2010. 

Jennifer Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2010–12153 Filed 5–19–10; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Health Resources and Services 

Administration 

Part C Early Intervention Services 

Grant Under the Ryan White HIV/AIDS 

Program 

AGENCY: Health Resources and Services 

Administration (HRSA), HHS . 

ACTION: Notice of Non-competitive 

Award of Part C Funds for the Rural 

Health Group. 

SUMMARY: HRSA will be awarding noncompetitively Part C funds to support 

comprehensive primary care services for 

persons living with HIV/AIDS, 

including primary medical care, 

laboratory testing, oral health care, 

outpatient mental health and substance 

abuse treatment, specialty and 

subspecialty care, referrals for health 

and support services and adherence 

monitoring/education services to the 

Rural Health Group in order to ensure 

continuity of critical HIV medical care 

and treatment services, and to avoid a 

disruption of HIV clinical care to clients 

in Henderson, North Carolina, and the 

surrounding counties. 

SUPPLEMENTARY INFORMATION: 

Grantee of record: Maria Parham 

Medical Center, Henderson, North 

Carolina. 

Intended recipient of the award: Rural 

Health Group, Roanoke Rapids, North 

Carolina. 

Amount of the award: $426,562 to 

ensure ongoing clinical services to the 

target population. 

Authority: Section 2651 of the Public 

Health Service Act, 42 U.S.C. 300ff-51. 

CFDA Number: 93.918. 

Project period: April 1, 2010, to June 

30, 2011. The period of support for this 

award is from April 1, 2010, to June 30, 

2011. 

Justification for the Exception to 

Competition 

Critical funding for HIV medical care 

and treatment services to clients in 

northern North Carolina will be 

continued through a non-competitive 

award to the Rural Health Group, 

because it has the fiscal and 

administrative infrastructure to 

administer the Part C Grant. This is a 

temporary replacement award, as the 

previous grant recipient serving this 

population notified HRSA that it could 

not continue providing services after 

March 31, 2010. HRSA’s HIV/AIDS 

Bureau identified the Rural Health 

Group as the best qualified entity for 

this temporary grant, because it is a 

community health center funded by 

section 330 of the Public Health Service 

Act. As of January 1, 2010, the Maria 

Parham Medical Center has contracted 

with the Rural Health Group to provide 

services temporarily, and the program 

staff has been transferred to the Rural 

Health Group. The Rural Health Group 

can ensure comprehensive services are 

provided including primary medical 

care including antiretroviral therapies; 

prevention education and medication 

adherence teaching; referrals for mental 

health, substance abuse and dental 

services; and on-site medical HIV case 

management services. The additional 

funding provided would enhance 

retaining the targeted population in 

care. The Rural Health Group is able to 

provide critical services with the least 

amount of disruption to the service 

population while the service area is recompeted. 

This supplement will cover the time 

period from April 1, 2010, through June 

30, 2011. This service area will be 

included in the upcoming competition 

for the Part C HIV Early Intervention 

Services for project periods starting July, 

2011. 

FOR FURTHER INFORMATION CONTACT: 

Kathleen Treat, by e-mail 

ktreat@hrsa.gov, or by phone at 301– 

443–7602. 

Dated: May 12, 2010. 

Mary K. Wakefield, 

Administrator. 

[FR Doc. 2010–12047 Filed 5–19–10; 8:45 am] 

BILLING CODE 4165–15–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Food and Drug Administration 

[Docket No. FDA–2010–N–0085] 

Preventive Controls for Fresh Produce; 

Request for Comments; Extension of 

the Comment Period 

AGENCY: Food and Drug Administration, 

HHS. 

ACTION: Notice; extension of the 

comment period. 

SUMMARY: The Food and Drug 

Administration (FDA) is extending to 

July 23, 2010, the comment period for 

a notice that appeared in the Federal 

Register of February 23, 2010 (75 FR 

8086). In that notice, FDA established a 

docket to obtain comments and 

information about current practices and 

conditions for the production and 

packing of fresh produce. The agency is 

extending this comment period to give 

interested parties additional time to 


wwoods2 on DSK1DXX6B1PROD with NOTICES_PART 1